Restless legs syndrome as a possible predictor for psychiatric disorders in parents of children with ADHD

European Archives of Psychiatry and Clinical Neuroscience

Volumn 261, Issue 4, 2011, Pages 285-291

  Steinlechner, Susanne ^a   Brüggemann, Norbert ^a   Sobottka, Vera ^a   Benthien, Alexander ^a   Behn, Birte ^a,b   Klein, Christine ^a   Schmid, Gabriele ^a   Lencer, Rebekka ^a,c  

^a UNIVERSITY OF LÜBECK   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

ADHD; Family history; Personality disorders; Phenotypic spectrum; Psychiatric disorders; Restless legs syndrome

Indexed keywords

ADULT; AGORAPHOBIA; ALCOHOL PSYCHOSIS; ANTISOCIAL BEHAVIOR; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DYSTHYMIA; FAMILY HISTORY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MOOD DISORDER; NEUROLOGIC EXAMINATION; OBSESSIVE COMPULSIVE DISORDER; PREVALENCE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; STRUCTURED INTERVIEW;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FAMILY HEALTH; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PARENTS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RESTLESS LEGS SYNDROME; YOUNG ADULT;

EID: 79960254151     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-010-0140-z     Document Type: Article

References (50)

1. M Dopfner D Breuer N Wille, et al. 2008 How often do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample-results of the BELLA study Eur Child Adolesc Psychiatry 17 Suppl 1 59 70 19132305 10.1007/s00787-008-1007-y
2. J Fayyad R De Graaf R Kessler, et al. 2007 Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder Br J Psychiatry 190 402 409 17470954 10.1192/bjp.bp.106.034389 1:STN:280:DC%2BD2s3mtFGitg%3D%3D (Pubitemid 46706952)
3. SV Faraone TJ Spencer CB Montano, et al. 2004 Attention-deficit/ hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care Arch Intern Med 164 1221 1226 15197048 10.1001/archinte.164.11. 1221 (Pubitemid 39030359)
4. SV Faraone KM Antshel 2008 Diagnosing and treating attention-deficit/ hyperactivity, disorder in adults World Psychiatry 7 131 136 18836579
5. A Thapar J Holmes K Poulton, et al. 1999 Genetic basis of attention deficit and hyperactivity Br J Psychiatry 174 105 111 10211163 10.1192/bjp.174.2.105 1:STN:280:DyaK1M3islKjuw%3D%3D (Pubitemid 29089283)
6. SV Faraone RH Perlis AE Doyle, et al. 2005 Molecular genetics of attention-deficit/hyperactivity disorder Biol Psychiatry 57 1313 1323 15950004 10.1016/j.biopsych.2004.11.024 1:CAS:528:DC%2BD2MXltFSrsrg%3D (Pubitemid 40798551)
7. JR Morrison MA Stewart 1971 A family study of the hyperactive child syndrome Biol Psychiatry 3 189 195 5163807 1:STN:280:DyaE2c7hs1aktw%3D%3D
8. SV Faraone AE Doyle E Mick, et al. 2001 Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder Am J Psychiatry 158 1052 1057 11431226 10.1176/appi.ajp.158.7.1052 1:STN:280:DC%2BD3MznsVegtw%3D%3D (Pubitemid 32623108)
9. N Lowe A Kirley Z Hawi, et al. 2004 Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes Am J Hum Genet 74 348 356 14732906 10.1086/381561 1:CAS:528:DC%2BD2cXhtlKiu7o%3D (Pubitemid 38168622)
10. W Retz M Rosler C Kissling, et al. 2008 Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/ hyperactivity disorder symptoms in adults J Neural Transm 115 323 329 17994190 10.1007/s00702-007-0822-5 1:CAS:528:DC%2BD1cXhvFygtbg%3D
11. J Biederman SV Faraone T Spencer, et al. 1993 Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder Am J Psychiatry 150 1792 1798 8238632 1:STN:280:DyaK2c%2FlslWjtA%3D%3D (Pubitemid 23356570)
12. RA Barkley KR Murphy D Kwasnik 1996 Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder Pediatrics 98 1089 1095 8951258 1:STN:280:DyaK2s7gvV2kug%3D%3D (Pubitemid 26399271)
13. WO Shekim RF Asarnow E Hess, et al. 1990 A Clinical and Demographic Profile of a Sample of Adults with Attention-Deficit Hyperactivity Disorder, Residual State Compr Psychiat 31 416 425 2225800 10.1016/0010-440X(90)90026-O 1:STN:280:DyaK3M%2FjtVGhtg%3D%3D (Pubitemid 20305300)
14. M Rösler W Retz K Yaqoobi E Burg P Retz-Junginger 2009 Attention deficit/hyperactivity disorder in female offenders: prevalence, psychiatric comorbidity and psychosocial implications Eur Arch Psychiatry Clin Neurosci 259 2 98 105 18806916 10.1007/s00406-008-0841-8
15. S Mannuzza RG Klein A Bessler, et al. 1998 Adult psychiatric status of hyperactive boys grown up Am J Psychiatry 155 493 498 9545994 1:STN:280:DyaK1c3gslKhsA%3D%3D (Pubitemid 28207444)
16. DE Comings 1994 Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. I. Drug abuse Drug Alcohol Depend 35 1 16 8082550 10.1016/0376-8716(94)90104-X 1:STN:280: DyaK2czmsVWrtw%3D%3D (Pubitemid 24135898)
17. A Ghanizadeh MR Mohammadi R Moini 2008 Comorbidity of psychiatric disorders and parental psychiatric disorders in a sample of Iranian children with ADHD J Atten Disord 12 149 155 18319376 10.1177/1087054708314601
18. SV Faraone TE Wilens C Petty, et al. 2007 Substance use among ADHD adults: implications of late onset and subthreshold diagnoses Am J Addict 16 Suppl 1 24 32 17453604 10.1080/10550490601082767
19. TE Wilens 2004 Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues Psychiatr Clin North Am 27 283 301 15063998 10.1016/S0193-953X(03)00113-8 (Pubitemid 38452768)
20. S Cortese E Konofal M Lecendreux, et al. 2005 Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature Sleep 28 1007 1013 16218085 (Pubitemid 41170937)
21. E Konofal S Cortese M Marchand, et al. 2007 Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children Sleep Med 8 711 715 17644481 10.1016/j.sleep.2007.04.022 (Pubitemid 47553547)
22. RP Allen P Stillman AJ Myers 2010 Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: prevalence and characteristics Sleep Med 11 31 37 19464949 10.1016/j.sleep.2009. 03.007
23. B Bjorvatn L Leissner J Ulfberg, et al. 2005 Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries Sleep Med 6 307 312 15923140 10.1016/j.sleep.2005.03.008 (Pubitemid 40867820)
24. SL Clardy X Wang PJ Boyer, et al. 2006 Is ferroportin-hepcidin signaling altered in restless legs syndrome? J Neurol Sci 247 173 179 16759669 10.1016/j.jns.2006.04.008 1:CAS:528:DC%2BD28XpsVKlu70%3D (Pubitemid 44339542)
25. J Winkelmann TC Wetter V Collado-Seidel, et al. 2000 Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients Sleep 23 597 602 10947027 1:STN:280: DC%2BD3M%2FlsVWgsw%3D%3D (Pubitemid 30636654)
26. AV Desai LF Cherkas TD Spector, et al. 2004 Genetic influences in self-reported symptoms of obstructive sleep apnoea and restless legs: a twin study Twin Res 7 589 595 15607009 10.1375/1369052042663841 (Pubitemid 39643560)
27. AJ Rothdach C Trenkwalder J Haberstock, et al. 2000 Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in augsburg elderly Neurology 54 1064 1068 10720275 1:STN:280: DC%2BD3c7otlaitQ%3D%3D (Pubitemid 30151846)
28. J Winkelmann M Prager R Lieb, et al. 2005 "Anxietas tibiarum": Depression and anxiety disorders in patients with restless legs syndrome J Neurol 252 67 71 15654556 10.1007/s00415-005-0604-7 1:STN:280: DC%2BD2M%2FislWisw%3D%3D (Pubitemid 40179020)
29. B Phillips W Hening P Britz, et al. 2006 Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll Chest 129 76 80 16424415 10.1378/chest.129.1.76 (Pubitemid 43265245)
30. Wittchen HU, Zaudig M, Fydrich T (1997) Strukturiertes Klinisches Interview für DSM-IV. Hogrefe-Verlag, Göttingen
31. P Retz-Junginger W Retz D Blocher HG Weijers GE Trott PH Wender, et al. 2002 Wender Utah rating scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults Nervenarzt 73 9 830 838 12215873 10.1007/s00115-001-1215-x 1:STN:280:DC%2BD38vlsleitA%3D%3D (Pubitemid 36062318)
32. M Roesler W Retz P Retz-Junginger, et al. 2004 Tools fort he diagnosis of attention-deficit/hyperactivity disorder in adults. Self-rating behaviour questionnaire (ADHS-SB) and diagnostic checklist (ADHS-DC) Nervenarzt 75 888 895 (Pubitemid 39312514)
33. AS Walters C LeBrocq A Dhar, et al. 2003 Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome Sleep Med 4 121 132 14592342 10.1016/S1389-9457(02)00258-7 (Pubitemid 36527232)
34. Endicott J, Andreasen N, Spitzer RL (1978) Family history research diagnostic criteria. Biometrics Research, New York Psychiatric Institute, New York
35. S Mosko M Zetin S Glen, et al. 1989 Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients J Clin Psychol 45 51 60 2925884 10.1002/1097-4679(198901)45:1<51::AID- JCLP2270450107>3.0.CO;2-H 1:STN:280:DyaL1M7nsFGjsA%3D%3D (Pubitemid 19061240)
36. Finckh U, Rommelspacher H, Kuhn S et al (1997) Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism. Pharmacogenetics 7:271-281 (Pubitemid 27356927)
37. TJ Renner M Gerlach M Romanos, et al. 2008 Neurobiology of attention-deficit hyperactivity disorder Nervenarzt 79 771 781 18553066 10.1007/s00115-008-2513-3 1:STN:280:DC%2BD1cvis1Olsg%3D%3D
38. M Maheswaran CA Kushida 2006 Restless legs syndrome in children MedGenMed 8 79 16926818
39. CJ Earley 2003 Clinical practice. Restless legs syndrome N Engl J Med 2 348 2103 2109 10.1056/NEJMcp021288 (Pubitemid 36583306)
40. M Rösler R Fischer R Ammer C Ose W Retz 2009 A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder Eur Arch Psychiatry Clin Neurosci 259 120 129 19165529 10.1007/s00406-008-0845-4
41. V Engert JC Pruessner 2008 Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate Curr Neuropharmacol 6 322 328 19587853 10.2174/157015908787386069 1:CAS:528:DC%2BD1MXisVSqurc%3D
42. D Wood F Reimherr PH Wender 1982 Effects of levodopa on attention deficit disorder, residual type Psychiatry Res 6 13 20 6949167 10.1016/0165-1781(82) 90033-6 1:STN:280:DyaL387islOquw%3D%3D (Pubitemid 12129504)
43. M Ernst LL Liebenauer D Tebeka, et al. 1997 Selegiline in ADHD adults: plasma monoamines and monoamine metabolites Neuropsychopharmacol 16 276 284 10.1016/S0893-133X(96)00243-6 1:STN:280:DyaK2s3kvVShsA%3D%3D (Pubitemid 27146188)
44. MR Mohammadi A Ghanizadeh J Alaghband-Rad, et al. 2004 Selegiline in comparison with methylphenidate in attention deficit hyperactivity disorder children and adolescents in a double-blind, randomized clinical trial J Child Adolesc Psychopharmacol 14 418 425 15650498 10.1089/cap.2004.14.418 (Pubitemid 39473127)
45. AS Walters DE Mandelbaum DS Lewin, et al. 2000 Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic therapy study group Pediatr Neurol 22 182 186 10734247 10.1016/S0887-8994(99)00152-6 1:STN:280:DC%2BD3c3gtVWqtQ%3D%3D (Pubitemid 30151158)
46. SS Hamilton J Armando 2008 Oppositional defiant disorder Am Fam Physician 78 861 866 18841736
47. H Soderstrom K Blennow AK Sjodin, et al. 2003 New evidence for an association between the CSF HVA:5-HIAA ratio and psychopathic traits J Neurol Neurosurg Psychiatry 74 918 921 12810780 10.1136/jnnp.74.7.918 1:STN:280:DC%2BD3s3otlOitw%3D%3D (Pubitemid 36782996)
48. M Cyr CS Brown 1998 Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder Drugs 56 215 223 9711446 10.2165/00003495-199856020-00005 1:CAS:528:DyaK1cXls1Kjsrk%3D (Pubitemid 28391518)
49. LB Silver 1999 Alternative (nonstimulant) medications in the treatment of attention deficit hyperactivity disorder in children Pediatr Clin North Am 46 965 975 10570699 10.1016/S0031-3955(05)70166-8 1:STN:280: DC%2BD3c%2Fjslaruw%3D%3D (Pubitemid 29477884)
50. MR Mohammadi L Kashani S Akhondzadeh, et al. 2004 Efficacy of theophylline compared to methylphenidate for the treatment of attention deficit hyperactivity disorder in children and adolescents: a pilot double-blind, randomized trial J Clin Pharm Ther 29 139 144 15068402 10.1111/j.1365-2710.2004. 00545.x 1:CAS:528:DC%2BD2cXktFKqsbY%3D (Pubitemid 38482478)